Kennedy Institute of Ethics Journal 19 (1):pp. 1-22 (2009)

Abstract
Direct reprogramming of human skin cells makes available a source of pluripotent stem cells without the perceived evil of embryo destruction, but the advent of such a powerful biotechnology entangles stem cell research in other forms of moral complicity. Induced pluripotent stem cell (iPSC) research had its origins in human embryonic stem cell research and the projected biomedical applications of iPS cells almost certainly will require more embryonic stem cell research. Policies that inhibit iPSC research in order to avoid moral complicity are themselves complicit in preventable harms to patients. Moral complicity may be unavoidable, but a Blue Ribbon Panel charged with assessing the need for additional embryonic stem cell lines may ease a transition from embryonic stem cell research to clinical applications of iPS cells.
Keywords No keywords specified (fix it)
Categories (categorize this paper)
DOI 10.1353/ken.0.0270
Options
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy


Upload a copy of this paper     Check publisher's policy     Papers currently archived: 57,156
Through your library

References found in this work BETA

No references found.

Add more references

Citations of this work BETA

The Moral Status of the Human Embryo.Mark T. Brown - 2018 - Journal of Medicine and Philosophy 43 (2):132-158.
Cloning.Katrien Devolder - 2008 - Stanford Encyclopedia of Philosophy.

Add more citations

Similar books and articles

Analytics

Added to PP index
2009-03-11

Total views
240 ( #36,324 of 2,411,735 )

Recent downloads (6 months)
5 ( #149,408 of 2,411,735 )

How can I increase my downloads?

Downloads

My notes